fashion -WSS

fashion

author：comprehensive 2025-10-02 01:07:21 - browse：56

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： UnitedHealth increases loan offers after Change Healthcare outage

WSS

SNAP should offer more nutrition education

Intermittent fasting comes with a heart risk? Not so fast

In Spain, a hospital brews its own CAR

Methadone treatment changes are coming. Do they go far enough?

Virtual Event: March of the Biosimilars

Physicians and social media: If you see something, say something?

leisure time

fashion

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Virtual Event: March of the Biosimilars

State Dept. review finds Biden bears some blame for Afghanistan failures

Grail spinoff by Illumina should end disastrous merger attempt

What does generative AI mean for health care? We asked experts

Carvykti CAR

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Plastic surgeons increase patient psychiatric screenings

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Nurses recount patients attacks

leisure time

Neuroscience’s long legacy of racism

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Stop the failed accountable care organization experiment

Christmas in the PICU brings some surprising joy

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

SEC charges former device maker CEO with $41 million fraud

hotspot

focus

explore

explore